Comparing lamivudine plus dolutegravir and bictegravir/emtricitabine/ tenofovir alafenamide in antiretroviral therapynaive HIV-infected patients: preliminary results from clinical practice

被引：0
|
作者：
Long, H. [1 ]
机构：
[1] Guiyang Publ Hlth Clin Ctr, Guiyang, Peoples R China
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
406
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [31] Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial
    Rossetti, Barbara
    Ferrara, Micol
    Taramasso, Lucia
    Bai, Francesca
    Lombardi, Francesca
    Ciccarelli, Nicoletta
    Durante, Miriam
    Alladio, Francesca
    Bonazza, Federica
    Rancan, Ilaria
    Montagnani, Francesca
    Di Biagio, Antonio
    Monforte, Antonella d'Arminio
    Zazzi, Maurizio
    Fabbiani, Massimiliano
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 293 - 304
  • [32] Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz plus lamivudine plus tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China
    Cao, Jing
    Tang, Wei
    Wang, Ning
    Zheng, Fang
    Xiao, Gang
    Wang, Xingzhi
    Zhou, Guoqiang
    Wang, Min
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [33] Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
    Podzamczer, Daniel
    Imaz, Arkaitz
    Lopez-Lirola, Ana
    Knobel, Hernando
    Masia, Mar
    Fanciulli, Chiara
    Hernandez, Cristina
    Lagarde, Maria
    Gutierrez, Angela
    Curran, Adria
    Morano, Luis
    Montero-Alonso, Marta
    Troya, Jesus
    Rigo, Raul
    Casadella, Maria
    Navarro-Alcaraz, Antonio
    Ardila, Fernando
    Parera, Mariona
    Bernal, Enrique
    Echeverria, Patricia
    Estrada, Vicente
    Hidalgo-Tenorio, Carmen
    Macias, Juan
    Prieto, Paula
    Portilla, Joaquin
    Valencia, Eulalia
    Vivancos, Maria Jesus
    Rivero, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2696 - 2701
  • [34] Switching to a single-tablet regimen bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) from dolutegravir (DTG) plus emtricitabine and either tenofovir alafenamide or tenofovir disoproxil fumarate (F/TAF or F/TDF)
    Sax, P. E.
    Rockstroh, J.
    Luetkemeyer, A.
    Yasdanpanah, Y.
    Ward, D.
    Trottier, B.
    Rieger, A.
    Liu, H.
    Acosta, R.
    Collins, S. E.
    Brainard, D.
    Martin, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 3 - 4
  • [35] Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy
    Andreatta, Kristen
    Sax, Paul E.
    Wohl, David
    D'Antoni, Michelle L.
    Liu, Hui
    Hindman, Jason T.
    Callebaut, Christian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,
  • [36] Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV
    Saborido-Alconchel, Abraham
    Serna-Gallego, Ana
    Lopez-Cortes, Luis E.
    Trujillo-Rodriguez, Maria
    Praena-Fernandez, Juan Manuel
    Dominguez-Macias, Montserrat
    Lozano, Carmen
    Munoz-Muela, Esperanza
    Espinosa, Nuria
    Roca-Oporto, Cristina
    Sotomayor, Cesar
    Herrero, Marta
    Gutierrez-Valencia, Alicia
    Lopez-Cortes, Luis F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (09) : 2354 - 2360
  • [37] HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data
    D'Antoni, Michelle L.
    Andreatta, Kristen
    Chang, Silvia
    Cox, Stephanie
    Hindman, Jason T.
    Avihingsanon, Anchalee
    Martin, Hal
    Vanderveen, Laurie A.
    Callebaut, Christian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (04) : 380 - 384
  • [38] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
    Al Soub, Hussam
    Al-khal, A. Latif M.
    Alsoub, Deema
    Awouda, Waleed
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [39] Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches
    Martin, Charlene
    Unal, Guillemette
    Plantier, Jean-Christophe
    Alessandri-Gradt, Elodie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2305 - 2307
  • [40] Safety and efficacy of lamivudine/dolutegravir vs. bictegravir/ emtricitabine/tenofovir alafenamide in antiretroviral- naive adults with HIV-1 infection in Shanghai, China: a single- centre retrospective study
    Yang, Junyang
    Wang, Lin
    Zhang, Xiaoran
    Liu, Li
    Shen, Yinzhong
    Qi, Tangkai
    Wang, Zhenyan
    Song, Wei
    Tang, Yang
    Xu, Shuibao
    Sun, Jianjun
    Chen, Youming
    Shen, Yihong
    Chen, Jun
    Zhang, Renfang
    JOURNAL OF MEDICAL MICROBIOLOGY, 2025, 74 (01)
12345